Votrient User Reviews & Ratings (Page 4)
Votrient has an average rating of 8.0 out of 10 from a total of 82 reviews on Drugs.com. 74% of reviewers reported a positive experience, while 9% reported a negative experience.
Reviews for Votrient
- Kat...
- October 8, 2020
For Soft Tissue Sarcoma "I have been taking Votrient for 5 years now. The tumors in my bones shrank a bit at first, but it stopped. It has stayed the same level for more than 5 years."
- Sho...
- Taken for 1 to 2 years
- August 6, 2018
For Renal Cell Carcinoma "I've had a very good experience with this drug and have been on it since Nov 2016. Diarrhea has been a side effect, but a small price to pay to feel overall very good!"
Frequently asked questions
- Does Votrient cure cancer or shrink tumors?
- How long does Votrient stay in your system?
- Is Votrient a chemotherapy treatment?
- Is Votrient immunotherapy?
- lll...
- Taken for 1 to 6 months
- May 21, 2018
For Renal Cell Carcinoma "With Votrient, I had no major side effects, only loss of appetite and weight loss so far. Slowed progression of cancer down significantly."
- Fly...
- Taken for 1 to 2 years
- November 15, 2016
For Soft Tissue Sarcoma "Have been on Votrient for almost 12 months. The first 6 months on 400 mg a day, sometimes not taking it at all because the side effects were so horrendous. Then it was upped to 800 mg a day."
Are you taking this medicine?
Your review helps others make informed decisions.- man...
- Taken for less than 1 month
- August 7, 2017
For Renal Cell Carcinoma "Started treatment 7 days ago, no real side effects, only lethargic all the time."
- Sum...
- Taken for 1 to 6 months
- November 3, 2016
For Renal Cell Carcinoma "My father had passed away after taking pazopanib for just 3 months due to tumor rupture because of this tablet. Please do not consume it."
Are you taking this medicine?
Your review helps others make informed decisions.More about Votrient (pazopanib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
For Soft Tissue Sarcoma "Have been on Votrient about six months. Virtually no side effects except for the white hair. Tumors are stable."